Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alexandra Z. Ripoll
MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status
International Journal of Cancer
Cancer Research
Oncology
Related publications
Correction: Cisplatin-Induced Epigenetic Activation of miR-34a Sensitizes Bladder Cancer Cells to Chemotherapy
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
miR‑34a Regulates the Chemosensitivity of Retinoblastoma Cells via Modulation of MAGE‑A/p53 Signaling
International Journal of Oncology
Cancer Research
Oncology
MicroRNA-34a (miR-34a)
Science-Business eXchange
MicroRNA-34a Is Induced via P53 During Cisplatin Nephrotoxicity and Contributes to Cell Survival
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells
Tumor-Suppressive miR-34a Induces Senescence-Like Growth Arrest Through Modulation of the E2F Pathway in Human Colon Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Elevated Circulating Stearic Acid Leads to a Major Lipotoxic Effect on Mouse Pancreatic Beta Cells in Hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent Pathway
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
